多沙唑嗪治疗原发性高血压38例疗效观察  

The effect of doxazosin mesylate therapy on 38 patients with essential hypertension

作　　者：李雄根[1] 廖习清[2] 赖真[3] 

机构地区：[1]深圳市人民医院肾内科,广东省深圳518020 [2]深圳市人民医院心内科,广东省深圳518020 [3]深圳市人民医院中医科,广东省深圳518020

出　　处：《中国基层医药》2008年第1期86-87,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的观察多沙唑嗪治疗原发性高血压的临床疗效。方法38例Ⅰ或Ⅱ期原发性高血压患者服用多沙唑嗪控释片4～8mg／d，4周，观察治疗前后诊所血压（CBP）、超声心动图及生化指标的变化。结果多沙唑嗪治疗后血压下降明显，总有效率87％，对血糖、血脂和心功能无不良影响。结论多沙唑嗪是治疗高血压的有效药物，安全、耐受性好。Objective To observe the effect of doxazosin mesylate（cardur） on essential hypertension. Methods The experiment was carried out by choosing 38 patients with essential hypertensive phase Ⅰ or Ⅱ to receive doxazosin（cardura） therapy. Clinic blood pressure （CBP）, ultrasonic cardiogram （UCG） and biochemic exams were investigated. Results The total effective rate was 87 % . No harmful reaction of blood glucose, blood lipid and cardiac function were found. Conclusion It was effective and safe that doxazosin was treated on essential hypertension patients with mild-moderate essential hypertension.

关 键 词：多沙唑嗪 原发性高血压 疗效 病例 

分 类 号：R544.1[医药卫生—心血管疾病] R972.4[医药卫生—内科学]